News Conference News European Congress on Obesity 2025 Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5 Michael O'Riordan May 12, 2025
News Features Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s? Michael O'Riordan January 17, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Daily News Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits Michael O'Riordan October 03, 2024
News Daily News Holistic Screening for Preeclampsia in First Trimester Bests Clinical Factors Alone Caitlin E. Cox May 20, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’ Michael O'Riordan July 24, 2023
News Daily News Brain Areas Identified Linking High BP and Cognitive Impairment Todd Neale March 31, 2023
News Conference News ACC 2023 Keto Diet Linked to Hypercholesterolemia, Higher ASCVD Risk Shelley Wood March 08, 2023
News Conference News ACC 2023 HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension Todd Neale March 08, 2023
News Daily News Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds L.A. McKeown December 29, 2022
News Daily News CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans Yael L. Maxwell July 22, 2022
News Daily News Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE Michael O'Riordan June 17, 2022
News Daily News Research Clarifies Link Between BP Problems in Pregnancy and Later CVD Yael L. Maxwell June 13, 2022
News Daily News Optimal Medical Therapy for Stable Angina: Which Drugs? How Long? Michael O'Riordan January 25, 2022
News Daily News CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD Yael L. Maxwell October 14, 2021
News Daily News Biomarker Levels ID Patients With Most to Gain From Intensive BP Lowering Todd Neale September 08, 2021
News Industry News First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial July 14, 2021